
An Infinite Canvas: The Future of Collaborative Storytelling with AI ft. Alec Pollak, EVP at NEON, an IPG Health Company
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Our Favorite Stories
- Alec's journey as the "Photoshop kid" at Grey Entertainment, helping build the Batman movie's first website.
- His reflections on surviving the Web 1.0 era and the exciting chaos of startups in 1990s New York.
- Using virtual reality for healthcare. Talk about ahead of the curve! Alec tells us about a 1993 college paper he wrote at Columbia on VR as a treatment for schizophrenia.
Big Moments from Doing the Work
- Alec's transition from startups to healthcare advertising, driven by his desire for stability after his daughter’s birth.
- Leading engagement strategy at Area 23 and Neon, crafting human-centered storytelling for pharmaceutical clients.
- Exploring the potential of AI tools like MidJourney and Leonardo.ai for creating impactful healthcare narratives.
Career Advice We’ll Live With
- Embrace storytelling non-linearly; start with the compelling "hook" and let context follow.
- Use new technologies as creative extensions, not replacements, to enhance ideation and storytelling efficiency.
- Stay curious and connected: Participate in communities (like MidJourney’s Discord) and actively seek inspiration from creators and innovators.
- Balance passion with teaching—spread your enthusiasm to inspire and uplift others in your field.
Find us us on Twitter, Instagram, and at The Bad Podcast dot com
Ce que les auditeurs disent de An Infinite Canvas: The Future of Collaborative Storytelling with AI ft. Alec Pollak, EVP at NEON, an IPG Health Company
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.